Robeco Schweiz’s Idexx Laboratories IDXX Stock Holding History

Robeco Schweiz’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,869	Closed	-$3.21M	–	159
2022 Q1	$3.21M	Hold	5,869	–	–	0.05%	141
2021 Q4	$3.87M	Buy	5,869 +946	+19%	+$594K	0.05%	135
2021 Q3	$3.06M	Hold	4,923	–	–	0.04%	136
2021 Q2	$3.11M	Buy	4,923 +364	+8%	+$201K	0.04%	133
2021 Q1	$2.23M	Buy	4,559 +1,633	+56%	+$818K	0.03%	131
2020 Q4	$1.46M	Buy	2,926 +833	+40%	+$373K	0.03%	140
2020 Q3	$823K	Sell	2,093 -32	-2%	-$11.8K	0.02%	139
2020 Q2	$702K	Sell	2,125 -441	-17%	-$128K	0.03%	130
2020 Q1	$618K	Sell	2,566 -317	-11%	-$82.7K	0.03%	125
2019 Q4	$754K	Hold	2,883	–	–	0.03%	124
2019 Q3	$786K	Sell	2,883 -258	-8%	-$71.8K	0.03%	126
2019 Q2	$855K	Buy	+3,141	New	+$774K	0.04%	123

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Robeco Schweiz's IDXX Position: Q2 2022 in Review

Robeco Schweiz sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 5,869 shares — an estimated $3.21M sold.

Robeco Schweiz first reported a position in IDXX in Q2 2019 and held it in 12 quarters. The position peaked at $3.87M in Q4 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

Robeco Schweiz reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
Robeco Schweiz sold 5,869 Idexx Laboratories shares in Q2 2022, an estimated $3.21M.
Robeco Schweiz first reported a position in Idexx Laboratories in Q2 2019 and held it in 12 quarters.
Robeco Schweiz's Idexx Laboratories position peaked at $3.87M in Q4 2021.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Robeco Schweiz's 13F filing for Q2 2022, filed 3 Aug 2022.